PharmaBiome is a privately-held spin-off company of ETH Zurich and a pioneer in the production of live biotherapeutic products to address disturbances of the gut microbiome. It has developed the first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science, PharmaBiome believes that the future of microbiome-based therapeutics lies in developing the biotechnology needed to produce a solution compatible with the safety, efficiency, and trial requirements of any human medicine. This holds the promise of becoming a first step into the creation of personalized treatments for patients with chronic inflammatory diseases, immune conditions, and special nutritional needs. PharmaBiome has invested years in developing a biology-based analysis tool that allows for the identification and selection of the metabolic functions needed to restore the gut microbiome to a balanced state. The resulting formulation compounds the over 500 different strains that every person hosts to a minimal consortium of bacteria representing a healthy microbiome. The co-culture of this bacterial mix transforms it into a live biotherapeutic product whose active principle is based on the composition, function, and interactions between the microorganisms. The flexibility and speed of this process are a unique advantage to bring to life effective treatment options. Over the years, it has been recognized with several start-up awards such as Venture Kick, the ETH Spark Award, and the BaseLaunch Accelerator.
View Top Employees from PharmaBiome AGWebsite | http://www.pharmabiome.com |
Revenue | $3 million |
Employees | 11 (8 on RocketReach) |
Founded | 2015 |
Address | 7 Schmelzbergstrasse, Zürich ETH-Zentrum, Zurich 8092, CH |
Phone | +41 44 254 16 18 |
Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Social/Platform Software, Business Services, Science and Engineering, Health Care, Medical |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies |
Looking for a particular PharmaBiome AG employee's phone or email?
The PharmaBiome AG annual revenue was $3 million in 2024.
Gabriel Leventhal is the Chief Scientific Officer of PharmaBiome AG.
8 people are employed at PharmaBiome AG.
PharmaBiome AG is based in Zürich ETH-Zentrum, Zurich.
The NAICS codes for PharmaBiome AG are [5417, 54, 541, 541713, 54171].
The SIC codes for PharmaBiome AG are [873, 87].